Portfolio managers should consider choosing CLOs and ABS over corporate credit and agency MBS over Treasuries in 2025, says ...

Marshall Crenshaw: 8 p.m. Thursday and Friday, March 20-21, at Space, 1245 Chicago Ave., Evanston. Pop, with Rachael Sage on ...

Incyte's revenues continues to grow, with full-year 2024 revenues reaching $4.2 billion, driven by JAKAFI and OPZELURA. Click ...

Adolescents with alopecia areata achieve hair regrowth with 80% or more of scalp coverage while taking the Janus kinase inhibitor baricitinib, a phase 3 study finds.

Twice-daily application of ruxolitinib cream demonstrated an ability to reduce itching and blistering in prurigo nodularis, a ...

To list the 12 Best Quality Stocks to Invest in Now, we sifted through the holdings of iShares MSCI USA Quality Factor ETF.

To list the 12 Best Quality Stocks to Invest in Now, we sifted through the holdings of iShares MSCI USA Quality Factor ETF.

HealthDay News — For adults with severe alopecia areata (AA), ivarmacitinib, a selective Janus kinase 1 (JAK1) inhibitor, at doses of 4 and 8mg is efficacious and tolerable, according to a study ...

Learn more about whether Janus Henderson Group plc or Piper Sandler Companies is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

For adults with severe alopecia areata (AA), ivarmacitinib, a selective Janus kinase 1 (JAK1) inhibitor, at doses o ...

"The supply/demand dynamic is a headwind for the muni market this week as supply is expected to be elevated," said Cooper ...

Remember when inflation was the biggest worry on Wall Street? A fleeting reaction in the bond market to a cooler-than-expected February consumer-price index reading on Wednesday is a signal that ...